Clinical Trial: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398287) titled 'Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease' on Jan. 13.

Brief Summary: The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).

Study Start Date: Feb. 15

Study Type: INTERVENTIONAL

Condition: Interstitial Lung Disease (ILD)

Intervention: DRUG: L-menthol

(Sigma-Aldrich, St. Louis, US)

OTHER: Placebo

Strawberry scent (Sigma-Aldrich, St. Louis, US)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Region Skane

Disclaimer: Curated by HT Syndication....